At this point we don't know. They could be in the works and announced tomorrow and today's offer sale allows the company to raise additional funds quickly (i.e. PCa gets small upfront payment of $10M and then additional $30M payment upon 510k approval). Maybe such terms don't provide cash soon enough so this is a way to raise funds quickly by executing warrants already held with a 1/2 share bonus. My interpretation of the extra 1/2 share is that no significant deal will be announced before the offer sale ends. If so, why would they need to offer an additional share if they were already lowering the exercise price and a significant deal was announced that popped the share price to $.60+?
It could mean any potential license deal doesn't provide enough upfront cash needed to get to revenue.
It could mean they are keeping HIV and not licensing it and this offering hopes to raise enough to build a commercialization team.
It could be a way to increase the MC quickly to increase any potential BO offers.
These are just a few examples and until explained we are guessing.
(0)
(0)
CytoDyn Inc (CYDY) Stock Research Links
Please do your own due diligence. All my posts and comments are not to be considered investment advice.